Evidence map›Paper›PMID 23325886›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes.

Elyara M Soares, Katie L Mason, Lisa M Rogers, Carlos H Serezani, Lucia H Faccioli, David M Aronoff

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Leukotrienes in Innate Immunity: Still Underappreciated after All These Years?Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  4. Article
  5. Article
  6. Melanin Produced bymSphere · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Protein kinase D mediates inflammatory responses of human placental macrophages to Group B Streptococcus.American journal of reproductive immunology (New York, N.Y. : 1989) · 2019
    Article
  11. Article
  12. Article
  13. Prostaglandins DJournal of lipid research · 2018
    Article
  14. Variation in Macrophage Phagocytosis ofPathogens & immunity · 2018
    Article
  15. Leukotriene BScientific reports · 2017
    Article
  16. Too much of a good thing: How modulating LTBSeminars in immunology · 2017
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Elyara M SoaresDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109, USA.
Katie L Mason
Lisa M Rogers
Carlos H Serezani
Lucia H Faccioli
David M Aronoff
VA Ann Arbor Healthcare System · USIndiana University School of MedicineMichigan Medicine · USSUPERA Park of Innovation and Technology of Ribeirão Preto · BRUniversidade de São Paulo · BR

Funding

PULMONARY CELLULAR AND MOLECULAR BIOLOGY TRAININGT32HL007749 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Robert Pickett Dickson · 1993 to 2026
$19.9M
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptorsR00HL103777 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI SEREZANI, C. HENRIQUE · 2012 to 2014
$713k
Regulation of Toll-like receptor-induced NFkB activation by Gai-coupled receptorsK99HL103777 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SEREZANI, C. HENRIQUE · 2010 to 2011
$242k
NHLBI NIH HHS HL103777-03NHLBI NIH HHS K99 HL103777NHLBI NIH HHS R00 HL103777NHLBI NIH HHS T32 HL007749NHLBI NIH HHS T32HL007749
6 · The paper itself

Abstract

Puerperal sepsis is a leading cause of maternal mortality worldwide. Streptococcus pyogenes [group A Streptococcus; (GAS)] is a major etiologic agent of severe postpartum sepsis, yet little is known regarding the pathogenesis of these infections. Tissue macrophages provide innate defense against GAS, and their actions are highly regulated. The intracellular second messenger cAMP can negatively regulate macrophage actions against GAS. Because leukotriene (LT) B(4) has been shown to suppress intracellular cAMP in macrophages, we hypothesized that it could enhance innate defenses against GAS. We assessed the capacity of LTB(4) to modulate antistreptococcal actions of human macrophages, including placental and decidual macrophages and used a novel intrauterine infection model of GAS in mice lacking the 5-lipoxygenase enzyme to determine the role of endogenous LTs in host defense against this pathogen. Animals lacking 5-lipoxygenase were significantly more vulnerable to intrauterine GAS infection than were wild-type mice and showed enhanced dissemination of bacteria out of the uterus and a more robust inflammatory response than did wild-type mice. In addition, LTB(4) reduced intracellular cAMP levels via the BLT1 receptor and was a potent stimulant of macrophage phagocytosis and NADPH oxidase-dependent intracellular killing of GAS. Importantly, interference was observed between the macrophage immunomodulatory actions of LTB(4) and the cAMP-inducing lipid PGE(2), suggesting that interplay between pro- and anti-inflammatory compounds may be important in vivo. This work underscores the potential for pharmacological targeting of lipid mediator signaling cascades in the treatment of invasive GAS infections.

Indexed as

AdolescentAdultAnimalsArachidonate 5-LipoxygenaseCells, CulturedFemaleGenetic Predisposition to DiseaseHumansImmunity, InnateLeukotriene B4MiceMice, Inbred C57BLMice, KnockoutPuerperal InfectionSepsisStreptococcal InfectionsArachidonate 5-LipoxygenaseLeukotriene B4

Identifiers

PMID23325886
PMCPMC3563855
OpenAlexW2151660981

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.